Novo Nordisk's market value has surged past Tesla's, driven by early trial results for it's new weight loss pill. The Danish company's shares soared 8% on Thursday, reaching a record high after the company's latest pill showed a remarkable 13 point 1% weight loss in participants over 12 weeks. With a market cap of 604 billion, Novo Nordisk is now the 12th most valuable company globally, exceeding Tesla's $569 billion.